Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
Gelteq Limited has commenced its first clinical trial for an antiparasitic drug candidate using its proprietary Gelteq® technology in the veterinary sector, aiming for FDA regulatory submission later in 2026. This milestone expands Gelteq’s footprint into animal health, building on previous FDA progress and targeting a large, growing market opportu…